vs
FIRST US BANCSHARES, INC.（FUSB）与Xilio Therapeutics, Inc.（XLO）财务数据对比。点击上方公司名可切换其他公司
Xilio Therapeutics, Inc.的季度营收约是FIRST US BANCSHARES, INC.的1.3倍（$13.7M vs $10.4M），Xilio Therapeutics, Inc.净利率更高（75.7% vs 20.4%，领先55.3%），FIRST US BANCSHARES, INC.自由现金流更多（$9.1M vs $-2.1M）
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
Xilio Therapeutics是一家临床阶段生物技术企业，专注开发用于多种癌症治疗的新型肿瘤选择性免疫疗法，其在研候选药物可在肿瘤微环境中特异性激活抗肿瘤免疫反应，降低全身性毒副作用，主要面向北美及全球其他地区的肿瘤患者群体。
FUSB vs XLO — 直观对比
营收规模更大
XLO
是对方的1.3倍
$10.4M
净利率更高
XLO
高出55.3%
20.4%
自由现金流更多
FUSB
多$11.2M
$-2.1M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.4M | $13.7M |
| 净利润 | $2.1M | $10.4M |
| 毛利率 | — | — |
| 营业利润率 | 28.1% | -86.5% |
| 净利率 | 20.4% | 75.7% |
| 营收同比 | 7.1% | — |
| 净利润同比 | 24.2% | 179.1% |
| 每股收益（稀释后） | $0.36 | $-3.74 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUSBXLO
| Q4 25 | $10.4M | $13.7M | ||
| Q3 25 | $10.5M | $19.1M | ||
| Q2 25 | $10.3M | $8.1M | ||
| Q1 25 | $9.8M | $2.9M | ||
| Q4 24 | $9.7M | — | ||
| Q3 24 | $10.1M | — | ||
| Q2 24 | $10.0M | — | ||
| Q1 24 | $9.9M | — |
净利润FUSBXLO
| Q4 25 | $2.1M | $10.4M | ||
| Q3 25 | $1.9M | $-16.3M | ||
| Q2 25 | $155.0K | $-15.8M | ||
| Q1 25 | $1.8M | $-13.3M | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | $2.1M | — |
营业利润率FUSBXLO
| Q4 25 | 28.1% | -86.5% | ||
| Q3 25 | 23.9% | -10.1% | ||
| Q2 25 | 1.6% | -177.7% | ||
| Q1 25 | 23.8% | -472.7% | ||
| Q4 24 | 23.8% | — | ||
| Q3 24 | 29.2% | — | ||
| Q2 24 | 27.4% | — | ||
| Q1 24 | 27.8% | — |
净利率FUSBXLO
| Q4 25 | 20.4% | 75.7% | ||
| Q3 25 | 18.4% | -85.4% | ||
| Q2 25 | 1.5% | -196.0% | ||
| Q1 25 | 18.1% | -452.7% | ||
| Q4 24 | 17.6% | — | ||
| Q3 24 | 22.0% | — | ||
| Q2 24 | 21.2% | — | ||
| Q1 24 | 21.3% | — |
每股收益（稀释后）FUSBXLO
| Q4 25 | $0.36 | $-3.74 | ||
| Q3 25 | $0.32 | $-0.11 | ||
| Q2 25 | $0.03 | $-0.16 | ||
| Q1 25 | $0.29 | $-0.18 | ||
| Q4 24 | $0.29 | — | ||
| Q3 24 | $0.36 | — | ||
| Q2 24 | $0.34 | — | ||
| Q1 24 | $0.34 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.5M | $137.5M |
| 总债务越低越好 | $10.9M | — |
| 股东权益账面价值 | $105.6M | $35.3M |
| 总资产 | $1.2B | $154.7M |
| 负债/权益比越低杠杆越低 | 0.10× | — |
8季度趋势，按日历期对齐
现金及短期投资FUSBXLO
| Q4 25 | $73.5M | $137.5M | ||
| Q3 25 | $54.7M | $103.8M | ||
| Q2 25 | $54.0M | $121.6M | ||
| Q1 25 | $56.0M | $89.1M | ||
| Q4 24 | $47.2M | — | ||
| Q3 24 | $82.3M | — | ||
| Q2 24 | $58.2M | — | ||
| Q1 24 | $60.2M | — |
总债务FUSBXLO
| Q4 25 | $10.9M | — | ||
| Q3 25 | $10.9M | — | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $10.9M | — | ||
| Q4 24 | $10.9M | — | ||
| Q3 24 | $10.9M | — | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $10.8M | — |
股东权益FUSBXLO
| Q4 25 | $105.6M | $35.3M | ||
| Q3 25 | $104.2M | $-8.1M | ||
| Q2 25 | $101.9M | $7.1M | ||
| Q1 25 | $101.2M | $10.7M | ||
| Q4 24 | $98.6M | — | ||
| Q3 24 | $98.5M | — | ||
| Q2 24 | $93.8M | — | ||
| Q1 24 | $92.3M | — |
总资产FUSBXLO
| Q4 25 | $1.2B | $154.7M | ||
| Q3 25 | $1.1B | $133.7M | ||
| Q2 25 | $1.1B | $133.8M | ||
| Q1 25 | $1.1B | $103.7M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
负债/权益比FUSBXLO
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | 0.11× | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $-2.0M |
| 自由现金流经营现金流 - 资本支出 | $9.1M | $-2.1M |
| 自由现金流率自由现金流/营收 | 87.2% | -15.3% |
| 资本支出强度资本支出/营收 | 31.1% | 0.7% |
| 现金转化率经营现金流/净利润 | 5.79× | -0.19× |
| 过去12个月自由现金流最近4个季度 | $16.0M | — |
8季度趋势，按日历期对齐
经营现金流FUSBXLO
| Q4 25 | $12.3M | $-2.0M | ||
| Q3 25 | $4.2M | $-17.5M | ||
| Q2 25 | $3.9M | $-14.5M | ||
| Q1 25 | $1.8M | $29.0M | ||
| Q4 24 | $7.8M | — | ||
| Q3 24 | $1.9M | — | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $825.0K | — |
自由现金流FUSBXLO
| Q4 25 | $9.1M | $-2.1M | ||
| Q3 25 | $3.6M | — | ||
| Q2 25 | $1.6M | $-14.9M | ||
| Q1 25 | $1.7M | $29.0M | ||
| Q4 24 | $5.7M | — | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $2.3M | — | ||
| Q1 24 | $-142.0K | — |
自由现金流率FUSBXLO
| Q4 25 | 87.2% | -15.3% | ||
| Q3 25 | 34.2% | — | ||
| Q2 25 | 16.0% | -184.0% | ||
| Q1 25 | 17.2% | 988.3% | ||
| Q4 24 | 58.2% | — | ||
| Q3 24 | 12.7% | — | ||
| Q2 24 | 23.5% | — | ||
| Q1 24 | -1.4% | — |
资本支出强度FUSBXLO
| Q4 25 | 31.1% | 0.7% | ||
| Q3 25 | 5.9% | 0.0% | ||
| Q2 25 | 21.8% | 5.0% | ||
| Q1 25 | 0.7% | 0.8% | ||
| Q4 24 | 21.6% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 9.8% | — |
现金转化率FUSBXLO
| Q4 25 | 5.79× | -0.19× | ||
| Q3 25 | 2.18× | — | ||
| Q2 25 | 25.16× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 0.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
